Yuma Goto
Minato, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Bleeding Events Associated With Continuing Antithrombotic Therapy During Transrectal Ultrasound-Guided Prostate Biopsy: A Propensity Score-Matched Analysis.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: January 19, 2026
Real-World Outcomes of Combination Therapy With Radium-223 and Enzalutamide Compared With Enzalutamide Alone in Patients With Metastatic Castration-Resistant Prostate Cancer.
Journal: Advances in urology
Published: September 08, 2025
Clinical features of medication-related osteonecrosis of the jaw in prostate cancer management.
Journal: BJU international
Published: July 19, 2025
Complete Response Case of Metastatic Hormone-Sensitive Prostate Cancer Treated With Triplet Therapy (Androgen Deprivation Therapy + Docetaxel + Darolutamide).
Journal: Cureus
Published: March 26, 2025
Organ-specific tumor response to enfortumab vedotin in metastatic urothelial carcinoma: a multicenter retrospective study.
Journal: Japanese journal of clinical oncology
Published: February 27, 2025
Bilateral vas deferens suturing to prevent inguinal hernias after radical prostatectomy.
Journal: BJUI compass
Published: February 19, 2025
A case of remarkable response to combined radiation therapy, enfortumab vedotin, and pembrolizumab in metastatic urothelial carcinoma.
Journal: International cancer conference journal
Published: December 15, 2024
Evaluation of optimal timing and therapeutic efficacy of radium-223 therapy for metastatic castration-resistant prostate cancer: a multicenter collaborative study.
Journal: Japanese journal of clinical oncology
Published: December 07, 2024
Optimal Cystoscopic Surveillance Schedule Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.
Journal: Clinical genitourinary cancer
Published: December 05, 2024
Optimal timing for initiating androgen receptor signaling inhibitor therapy in patients with nonmetastatic castration-resistant prostate cancer: a multicenter collaborative study.
Journal: Japanese journal of clinical oncology
Published: September 02, 2024
Last Updated: 09/26/2026